Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines

Sensitization of mesothelioma cells to platinum-based chemotherapy by GSTπ knockdown

(2014) Jianli Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Mechanism of Glutathione Transferase P1-1-Catalyzed Activation of the Prodrug Canfosfamide (TLK286, TELCYTA)

(2013) Daniel F. A. R. Dourado et al.   BIOCHEMISTRY

Downregulation of glutathione transferase π sensitizes lymphoma/leukaemia cells to platinum-based chemotherapy

(2013) Jianli Chen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer

(2012) G Smith et al.   BRITISH JOURNAL OF CANCER

Glutathione S-transferase P1-1 as a target for mesothelioma treatment

(2012) Anastasia De Luca et al.   CANCER SCIENCE

miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1

(2012) Xuelin Zhang et al.   LUNG CANCER

Oxidative Processing of Latent Fas in the Endoplasmic Reticulum Controls the Strength of Apoptosis

(2012) V. Anathy et al.   MOLECULAR AND CELLULAR BIOLOGY

Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity

(2011) Kai-Hui Sun et al.   JOURNAL OF NEUROCHEMISTRY

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells

(2010) Yue Wang et al.   CANCER LETTERS

GSTP1-1 in Ovarian Cyst Fluid and Disease Outcome of Patients With Ovarian Cancer

(2009) E. Kolwijck et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro

(2008) Hironobu Yanagie et al.   BIOMEDICINE & PHARMACOTHERAPY

Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin

(2008) Christina Peklak-Scott et al.   MOLECULAR CANCER THERAPEUTICS